<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: Exceptionally Selective D2 Dopamine Receptor Antagonists as Therapeutics</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: Exceptionally Selective D2 Dopamine Receptor Antagonists as Therapeutics</h1>
    <p class="timestamp">Published: 2025-06-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Institute of Neurological Disorders and Stroke and the National Center for Advancing Translational Sciences, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this Notice to Psycala Bio, Inc. (Psycala), incorporated in Delaware.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2025-09844</p>
    <p><strong>Publication Date:</strong> 2025-06-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/06/02/2025-09844/prospective-grant-of-an-exclusive-patent-license-exceptionally-selective-d2-dopamine-receptor">https://www.federalregister.gov/documents/2025/06/02/2025-09844/prospective-grant-of-an-exclusive-patent-license-exceptionally-selective-d2-dopamine-receptor</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-09844</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
